Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Askal Ayalew Ali
Using Quality-Adjusted Progression-Free Survival as an Outcome Measure to Assess the Benefits of Cancer Drugs in Randomized-Controlled Trials: Case of the BOLERO-2 Trial
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
P1.15-29 Impact of Radiation Therapy Quality Assurance on Progression-Free and Overall Survival in Randomized Trials of Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Using Routinely Recorded Data in the UK to Assess Outcomes in a Randomised Controlled Trial: The Trials of Access
Trials
Medicine
Pharmacology
Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs
JAMA network open
Medicine
Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail the Last Barrier?
International Journal of Cancer
Cancer Research
Oncology
Description of the Protocols for Randomized Controlled Trials on Cancer Drugs Conducted in Spain (1999–2003)
PLoS ONE
Multidisciplinary
Evolving Options for the Treatment of Metastatic Breast Cancer: Progression-Free Survival as an Endpoint
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
Use of Continuous Glucose Monitoring as an Outcome Measure in Clinical Trials
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
TRIal to Slow the Progression of Diabetes (TRIPOD): Study Protocol for a Randomized Controlled Trial Using Wireless Technology and Incentives
Trials
Medicine
Pharmacology
Perspectives of Patients With Cancer on the Quality-Adjusted Life Year as a Measure of Value in Healthcare
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
